Results 241 to 250 of about 37,007 (262)
Some of the next articles are maybe not open access.

Recent advances in the design of Hedgehog pathway inhibitors for the treatment of malignancies

Expert Opinion on Drug Discovery, 2014
The Hedgehog (Hh) signaling pathway is known to be dysregulated in several forms of cancer. Hence, specifically targeting this signaling cascade is a valid and promising strategy for successful therapeutic intervention. Several components within the Hh pathway have been proven to be druggable; however, challenges in the discovery and development ...
Upasana, Banerjee, Matthew Kyle, Hadden
openaire   +2 more sources

Hedgehog Pathway Inhibitors

2021
Shauna Higgins, Ashley Wysong
openaire   +1 more source

Inhibitors of the Hedgehog Signal Transduction Pathway

Current Cancer Therapy Reviews, 2005
David Robbins   +3 more
openaire   +1 more source

Hedgehog Pathway Inhibitors for Periocular Basal Cell Carcinoma

International Ophthalmology Clinics, 2020
Davin C, Ashraf, M Reza, Vagefi
openaire   +2 more sources

Multitarget hedgehog pathway inhibitors and uses thereof

2014
The present invention concerns compds. that selectively inhibit the activity of the Hedgehog (Hh) pathway, their prepn. and uses thereof. The compds. of the present invention are useful in treating Hh-​dependent tumors, such as medulloblastoma (MB)​.
BOTTA, Bruno   +9 more
openaire   +2 more sources

Development of taladegib as a sonic hedgehog signaling pathway inhibitor

Archives of Pharmacal Research, 2017
Guanghai Jin   +2 more
openaire   +2 more sources

Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib

Journal of the American Academy of Dermatology, 2014
Anne Lynn S Chang   +2 more
exaly  

Home - About - Disclaimer - Privacy